Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Mult Scler ; 20(7): 862-70, 2014 06.
Article in English | MEDLINE | ID: mdl-24166355

ABSTRACT

OBJECTIVES: To identify clinical predictors of effectiveness of a motor rehabilitation treatment in a cohort of multiple sclerosis (MS) patients. MATERIALS AND METHODS: We analysed 212 consecutive patients who underwent a short-term (3-7 weeks) intensive (two hours per day, five days per week), individualised, goal-oriented inpatient rehabilitation program. Activity limitation and impairment were measured on admission and discharge of the rehabilitation trial using the motor sub-items of the Functional Independence Measure (mFIM) and the Expanded Disability Status Scale (EDSS) score. Multivariate logistic regression models have been tested to evaluate the role of clinical baseline features on rehabilitation effectiveness. RESULTS: According to pre-defined outcome measures, 75.1% of MS patients improved in either activity limitation (≥5 points delta mFIM) or impairment (≥1.0 delta EDSS score if baseline EDSS was ≤5.5, or ≥0.5 if baseline EDSS was >5.5), and 35.4% of MS patients improved in both outcomes. A relapsing-remitting course of disease, a more severe baseline impairment and activity limitation level, a shorter disease duration and a less severe balance dysfunction were predictive of the effectiveness of rehabilitation. DISCUSSION: These data confirm that an intensive inpatient rehabilitation program is able to produce a short-term relevant improvement on clinical and functional outcome measures and suggest some clinical features which can be considered as potential predictors of the outcome of rehabilitative intervention.


Subject(s)
Exercise Therapy/methods , Mobility Limitation , Motor Activity , Multiple Sclerosis, Chronic Progressive/rehabilitation , Multiple Sclerosis, Relapsing-Remitting/rehabilitation , Adult , Aged , Combined Modality Therapy , Disability Evaluation , Female , Humans , Inpatients , Logistic Models , Male , Middle Aged , Multiple Sclerosis, Chronic Progressive/diagnosis , Multiple Sclerosis, Chronic Progressive/physiopathology , Multiple Sclerosis, Relapsing-Remitting/diagnosis , Multiple Sclerosis, Relapsing-Remitting/physiopathology , Multivariate Analysis , Odds Ratio , Patient Care Team , Patient Discharge , Recovery of Function , Severity of Illness Index , Time Factors , Treatment Outcome , Young Adult
2.
Neuroscience ; 248: 333-43, 2013 Sep 17.
Article in English | MEDLINE | ID: mdl-23727509

ABSTRACT

Therapeutic strategies for the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS) are actually minimally effective on patients' survival and quality of life. Although stem cell therapy has raised great expectations, information on the involved molecular mechanisms is still limited. Here we assessed the efficacy of the systemic administration of adipose-derived mesenchymal stem cells (ASC), a previously untested stem cell population, in superoxide-dismutase 1 (SOD1)-mutant transgenic mice, the animal model of familial ALS. The administration of ASC to SOD1-mutant mice at the clinical onset significantly delayed motor deterioration for 4-6 weeks, as shown by clinical and neurophysiological tests. Neuropathological examination of ASC-treated SOD1-mutant mice at day 100 (i.e. the time of their best motor performance) revealed a higher number of lumbar motorneurons than in phosphate-buffered saline-treated SOD1-mutant mice and a restricted number of undifferentiated green fluorescent protein-labeled ASC in the spinal cord. By examining the spinal cord tissue factors that may prolong neuronal survival, we found a significant up-regulation in levels of glial-derived neurotrophic factor (GDNF) and basic fibroblast growth factor (bFGF) after ASC treatment. Considering that ASC produce bFGF but not GDNF, these findings indicate that ASC may promote neuroprotection either directly and/or by modulating the secretome of local glial cells toward a neuroprotective phenotype. Such neuroprotection resulted in a strong and long-lasting effect on motor performance and encourages the use of ASC in human pathologies, in which current therapies are not able to maintain a satisfying neurological functional status.


Subject(s)
Amyotrophic Lateral Sclerosis/therapy , Mesenchymal Stem Cell Transplantation/methods , Mesenchymal Stem Cells/cytology , Motor Activity , Motor Neurons/cytology , Neuroprotective Agents , Adiposity , Amyotrophic Lateral Sclerosis/pathology , Amyotrophic Lateral Sclerosis/physiopathology , Animals , Disease Models, Animal , Fibroblast Growth Factor 2/metabolism , Glial Cell Line-Derived Neurotrophic Factor/metabolism , Male , Mesenchymal Stem Cells/physiology , Mice , Mice, Transgenic , Motor Neurons/metabolism , Motor Neurons/physiology , Spinal Cord/cytology , Superoxide Dismutase/genetics , Superoxide Dismutase-1 , Treatment Outcome , Up-Regulation
3.
Neurol Sci ; 34(2): 209-15, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22367224

ABSTRACT

Botulinum toxin type-A is currently thought to be effective and safe for hemifacial spasm (HFS). The pre-synaptic block of acetylcholine release at the neuromuscular junction induces depression of orbicularis oculi muscle compound motor action potential (CMAP). The aim of our study was to evaluate at what extent end-plate functional recovery is possible even in botulinum toxin treatments lasting up to 15 years. We examined 81 outpatients with primary HFS (mean treatment duration = 7.2 ± 4.2 years) who underwent neurophysiologic study, once clinical effect of the previous treatment had vanished. The mean CMAP amplitude, mean rectified amplitude of response 1 (R1) of the blink reflex and area of response 2 (R2) of treated orbicularis oculi muscle were measured in comparison to the controlateral side. Mean amplitude of the above mentioned parameters was slightly lower (about 20%; p < 0.001) in the treated side at the end of the follow-up period (4.7 ± 1.7 months). The CMAP amplitude reduction weakly correlated with the interval from last treatment, while other neurophysiologic parameters did not change due to treatment duration or total toxin amount. Our study demonstrates that botulinum toxin affects compound motor action potential and blink-reflex responses for at least 4-5 months in HFS patients. The residual block is slight and does not increase with repeated injections after several years of treatment. Our study, beside confirming the long-term efficacy of botulinum toxin treatment for HFS, provides neurophysiologic evidence that therapeutic effect may be obtained without hindering the regenerative potential of the nerve-muscle complex.


Subject(s)
Botulinum Toxins, Type A/therapeutic use , Hemifacial Spasm/drug therapy , Motor Endplate/physiology , Neural Conduction/physiology , Neuromuscular Agents/therapeutic use , Adult , Aged , Botulinum Toxins, Type A/pharmacology , Electromyography , Female , Hemifacial Spasm/physiopathology , Humans , Male , Middle Aged , Motor Endplate/drug effects , Muscle, Skeletal/drug effects , Muscle, Skeletal/physiopathology , Neural Conduction/drug effects , Neuromuscular Agents/pharmacology , Recovery of Function/drug effects , Recovery of Function/physiology , Treatment Outcome
4.
J Hazard Mater ; 78(1-3): 261-80, 2000 Nov 03.
Article in English | MEDLINE | ID: mdl-10978570

ABSTRACT

Participation is a major issue in environmental research and policy. Public Risk Perception and European Environmental Policy (PRISP), a cross-national inquiry on people's orientations about chemical risks, offered the opportunity to investigate some aspects. In two Italian case studies, interest was focused on the relation between experts and lay people and the function of participation. A key objective was to explore people's opinions about deliberative democracy. This is a currently much-debated alternative to the prevailing 'strategic' forms of democracy, based on the aggregation of preferences or bargaining among conflicting interests. Is there a role for an open confrontation aimed at reaching the common good? Results show that public interest is highly rated, participation is mainly connected to citizenship and understood as a form of co-operation. In a third case study, interest was focused on the analysis of a specific form of collective action according to the 'Critical Mass' rational choice model. In this case, it is argued that a small group of citizens may reduce the costs of starting-up a collective action aimed at pursuing the preferred social goals, i.e. at governing public goods.


Subject(s)
Hazardous Waste/legislation & jurisprudence , Health Planning/legislation & jurisprudence , Risk Assessment/legislation & jurisprudence , Technology/trends , Communication , Italy , Technology/economics
SELECTION OF CITATIONS
SEARCH DETAIL
...